SCHEMBL30424929

SCHEMBL30424929

[2H]C([2H])(c1cc(F)c(-c2nnc(C(F)F)o2)cc1F)n1cc(-c2ccc(N)nc2)nn1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 18/20 0.36
▸ DPP4 P27487 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25256806 1.00 HDAC6 (0.36) HDAC6DPP4
SCHEMBL25270176 0.91 HDAC6 (0.40) HDAC6DPP4
SCHEMBL30424962 0.91 HDAC6 (0.40) HDAC6DPP4
SCHEMBL30425139 0.90 HDAC1 (0.40) HDAC6
SCHEMBL25387302 0.90 HDAC1 (0.40) HDAC6
SCHEMBL25387589 0.88 HDAC6 (0.39) HDAC6
SCHEMBL30424906 0.88 HDAC6 (0.39) HDAC6
SCHEMBL25239939 0.87 HDAC6 (0.36) HDAC6
SCHEMBL30425778 0.87 HDAC6 (0.36) HDAC6
SCHEMBL25266944 0.83 HDAC6 (0.45) HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN claimed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN claimed
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN disclosed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback